Indeed, lessons from anti–TNF-α therapy suggest that targeting proinflammatory cytokines can increase the risk of infection.34,35 In contrast, in those with neutrophilic inflammation without evidence of bacterial colonization, particularly in those with asthma, the neutrophilic inflammation might be critical in the development of the disease. The gene discussed is TNF; the disease is asthma.